美国食品和药物管理局批准了安妮亚药业的注射乳液普罗波,解决了麻醉药物短缺问题. Amneal Pharmaceuticals receives FDA approval for Propofol Injectable Emulsion, addressing anesthesia drug shortage.

美国食品和药物管理局批准了Amneal Pharmaceuticals的Propofol注射乳液单剂量瓶,这是医院麻醉和镇静的重要药物. Amneal Pharmaceuticals received FDA approval for its Propofol Injectable Emulsion Single Dose Vials, an essential drug for anesthesia and sedation in hospitals. 批准的目的是解决这种药物严重短缺的问题,并通过增加关键麻醉治疗的供应来改善病人的护理。 The approval aims to address the critical shortage of this drug and improve patient care by increasing the supply of crucial anesthetic treatments. 该公司计划在2024年第四季度推出该产品。 The company plans to launch the product in the fourth quarter of 2024.